EUCTR2018-004287-56-FR进行中(未招募)1 期
Randomized placebo-controlled trial comparing Methotrexate vs. Methotrexate/Metformin association in rheumatoid arthritis patients: METorMET² study - METorMET2
CHU de Bordeaux0 个研究点目标入组 128 人开始时间: 2020年1月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 128
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patients aged over 18 years old,
- •- Patient affected by RA according to ACR 2010 criteria
- •- DAS28 > 3.2
- •- Methotrexate naïve patients, or without any methotrexate intake for more than six months.
- •- Men who accept to take active contraception during the study and during six months after the end of the Methotrexate treatment. Partner of patient will be informed of teratogenicity of MTX and will be advised to be on effective contraceptives for all the study duration.
- •- Women with a negative test of ß-HCG who accept to take active contraception during the study and during six months after the end of the Methotrexate treatment
- •- Patients without any Metformin previous therapy.
- •- Being affiliated to a health insurance system
- •- Having signed an informed consent form (later than the day of inclusion and before any examination required by the research)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 108
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •- Patient who present contraindications to treatment with Methotrexate or Metformin
- •- Patient with daily corticosteroid treatment at a dosage = 15 mg/day within four weeks before the inclusion
- •- History of allergy or intolerance to biguanide
- •- Renal insufficiency with clearance < 60 ml/mn
- •- Decompensated heart failure
- •- Coronary insufficiency
- •- Severe respiratory insufficiency
- •- Hepatic insufficiency
- •- Acute infection
- •- Critical ischemia of the lower limbs
- •- Recent stroke
- •- B12 Vitamin deficiency
- •- Patient performing or planning to perform a long-fasting period
- •- Pregnant or breastfeeding women
- •- Patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent).
研究者
相似试验
进行中(未招募)
1 期
Methotrexate and Metformin in rheumatoid arthritis patients.rheumatoid arthritis (RA)MedDRA version: 20.0Level: HLTClassification code: 10039075Term: Rheumatoid arthritis and associated conditions Class: 10021428CTIS2024-511033-35-00Centre Hospitalier Universitaire De Bordeaux128
尚未招募
1 期
Study to see if discontinuation of oxytocin in active phase of induced labours has an effect on the maternal and fetal outcomes.CTRI/2019/08/020657FLUID GRANT INSTITUTIONA
已完成
不适用
A double-blind, placebo-controlled trial of methylphenidate in children with hyperkinetic disorder and moderate-severe learning disabilitiesISRCTN68384912King's College London (UK)180
进行中(未招募)
1 期
A clinical trial of methylphenidate and lisdexamphetamine treatment in adults with attention-deficit hyperactivity disorderAttention Deficit Hyperactivity DisorderEUCTR2017-000368-14-SESahlgrenska Univerisity Hospital Gothenburg120
招募中
2 期
Efficacy of Methylphenidate Treatment in Children with Neurofibromatosis type 1 (NF1): A randomised, placebo controlled, cross over trialNeurofibromatosis type 1ACTRN12611000765921The Children's Hospital at Westmead36
